Co-opting the bacterial lipoprotein pathway for the biosynthesis of lipidated macrocyclic peptides
Proceedings of the National Academy of Sciences · 07.04.2026 · 123 (14)
DOI: 10.1073/pnas.2532672123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.03.2026. Verfasst von Jeff Y Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and HHMI, University of Illinois at Urbana-Champaign, Urbana, IL 61801. Hauptthemen laut MEDLINE: Lipoproteins, Bacterial Proteins, Peptides, Cyclic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCRR NIH HHS, NIGMS NIH HHS, HHMI (HHMI).
Abstract (Originalsprache)
Ribosomally synthesized and posttranslationally modified peptides (RiPPs) are structurally diverse natural products that possess a range of bioactivities, often acting as antibiotics, antifungals, or metallophores. In RiPP biosynthesis, different modifying enzymes install an array of chemical motifs onto a precursor peptide. A recently described RiPP-modifying enzyme, ChrH, catalyzes a remarkably complex reaction on its precursor peptide that results in a macrocycle, heterocycle, and S- methyl group. By leveraging comparative genomics, we demonstrate that the products from a subfamily of enzymes related to ChrH display unexpected structural diversity, including the production of unmethylated macrocyclic congeners and C-terminally modified proteins over 30 kDa in size. Several of these precursors contain a signal peptide, sending them for downstream maturation by the bacterial lipoprotein biosynthetic pathway. Like bacterial lipoproteins, such peptides are modified by addition of a diacylglycerol (DAG) group to the N-terminal cysteine residue along with acylation of the N-terminal amine. Genome mining reveals that these RiPP–lipoprotein hybrids, which we term DAG-RiPPs, are widespread across bacterial phyla and are likely involved in different biological roles. Together, these results highlight a maturation paradigm for membrane-bound RiPPs and lay the foundation for the future discovery and bioengineering of other RiPP–lipoprotein hybrids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and HHMI, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
- Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
- School of Chemical Sciences, Nuclear Magnetic Resonance Laboratory, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
ORCID-Profile: Jeff Y Chen, Lingyang Zhu, Kevin Y Zhang, Wilfred A van der Donk
Förderung
- NCRR NIH HHS
- NIGMS NIH HHS
- HHMI (HHMI)
- HHS | NIH (NIH)
Zitieren
APA
Chen, J. Y., Zhu, L., Zhang, K. Y., Berthold, D. A., & van der Donk, W. A. (2026). Co-opting the bacterial lipoprotein pathway for the biosynthesis of lipidated macrocyclic peptides. Proceedings of the National Academy of Sciences, 123(14). https://doi.org/10.1073/pnas.2532672123
Vancouver
Chen JY, Zhu L, Zhang KY, Berthold DA, van der Donk WA. Co-opting the bacterial lipoprotein pathway for the biosynthesis of lipidated macrocyclic peptides. Proceedings of the National Academy of Sciences. 2026;123(14). doi:10.1073/pnas.2532672123
BibTeX
@article{Chen2026,
author = {Chen, Jeff Y and Zhu, Lingyang and Zhang, Kevin Y and Berthold, Deborah A and van der Donk, Wilfred A},
title = {Co-opting the bacterial lipoprotein pathway for the biosynthesis of lipidated macrocyclic peptides},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {14},
doi = {10.1073/pnas.2532672123}
}
EUVIMED